REAL-WORLD COSTS OF FRONT-LINE TREATMENT FOR PERIPHERAL T-CELL LYMPHOMA IN FRANCE, GERMANY, AND THE UNITED KINGDOM

被引：0
|
作者：
Ashaye, A. [1 ]
Shah, R. [2 ]
Corman, S. [2 ]
Dalal, M. R. [1 ]
Fox, C. [3 ]
Trumper, L. [4 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Pharmerit, Bethesda, MD USA
[3] Nottingham Univ Hosp NHS Trust, Nottingham, England
[4] Georg August Univ, Univ Med, Gottingen, Germany
来源：
VALUE IN HEALTH | 2021年 / 24卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN62
引用
收藏
页码：S30 / S30
页数：1
相关论文
共 50 条
  • [1] Patient and Physician Preferences for Front-Line Treatment of Advanced Stage Hodgkin Lymphoma in Germany, France and the United Kingdom
    Broeckelmann, Paul
    Stamatoullas, Aspasia
    McMullen, Suzanne
    Wilson, Ben
    Mueller, Kerstin
    Goring, Sarah
    Zagadailov, Erin
    Gautam, Ashish
    Huebner, Dirk
    Dalal, Mehul
    Illidge, Tim M.
    BLOOD, 2017, 130
  • [2] Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma
    Moskowitz, Alison
    Advani, Ranjana H.
    Ganesan, Nivetha
    Chang, Tiffany
    Hancock, Helen
    Davey, Theresa
    Miller, Tayler
    Gibaldi, Angela
    Smith, Marcel
    Assini, Alicia
    Sarmasti, Lisa
    Collins, Paige
    Patel, Suviasini
    Le, Andrew K. N.
    Maccaro, Catherine
    Casper, Ellie
    Galasso, Natasha
    Subzwari, Sarima
    Jihad, Marwah
    Ghione, Paola
    Hoppe, Richard T.
    Imber, Brandon S.
    Johnson, William T.
    Owens, Colette
    Vardhana, Santosha A.
    Schoder, Heiko
    Yahalom, Joachim
    Horwitz, Steven
    BLOOD, 2024, 144 : 3068 - 3069
  • [3] Real-world treatment patterns, healthcare resource utilization and costs among patients with peripheral T-cell lymphoma
    Dharmani, Charles
    Unni, Sudhir
    Pham, Ngan
    Shaikh, Nazneen Fatima
    Xiong, Yan
    Vashi, Rohan
    Fofah, Oluwatosin
    Strubing, Alessandria
    Salas, Maribel
    Tu, Nora
    Wooddell, Margaret
    Zhou, Xiaoyu
    Near, Aimee
    FUTURE ONCOLOGY, 2024, 20 (15) : 1013 - 1030
  • [4] Real-World Multiple Myeloma Front-Line Treatment and Outcomes By Transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    BLOOD, 2022, 140 : 7187 - 7188
  • [5] Real-world multiple myeloma front-line treatment and outcomes by transplant in the United States
    Richter, Joshua
    Pan, Darren
    Salinardi, Taylor
    Rice, Megan S.
    EJHAEM, 2023, 4 (04): : 984 - 994
  • [6] Treatment outcomes of IMEP as a front-line chemotherapy for patients with peripheral T-cell lymphomas
    Lee, Ji Young
    Lee, Sang Min
    Choi, Moon Young
    Kim, Ki Hyang
    Joo, Young Don
    Im, Sung Nam
    Lee, Won Sik
    BLOOD RESEARCH, 2016, 51 (03) : 187 - 192
  • [7] Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma
    Kalac, Matko
    Jain, Salvia
    Tam, Constantine S.
    Xiao, Zhengrui
    Montanari, Francesca
    Kanakry, Jennifer
    Huber, Bryan D.
    Goldfinger, Mendel
    O'Connor, Owen A.
    Marchi, Enrica
    BLOOD ADVANCES, 2023, 7 (14) : 3760 - 3763
  • [8] Front-line chemotherapy treatment with gemcitabine in 20 cutaneous T-cell lymphoma patients.
    Zinzani, PL
    BLOOD, 2003, 102 (11) : 642A - 642A
  • [9] Front-line treatment of mantle cell lymphoma
    Geisler, Christian H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1241 - 1243
  • [10] Impact of Front-Line Treatment Interim PET/CT in Peripheral T-Cell Lymphoma Patients' Survival: Experience of a Single Center
    Rampi, Nicolo
    Cortes-Romera, Montserrat
    Lopez-Pereira, Patricia
    Martinez-Ramos, Carolina
    Montane Carbo, Clara
    Arevalo Leon, Carolina Esther
    De Oliveira, Ana C.
    Gonzalez Barca, Eva Maria
    Sureda Balari, Anna Maria
    Domingo Domenech, Eva
    BLOOD, 2023, 142
12345